J&J | JNJ - Umlaufvermögen





Umlaufvermögen Veränderung Datum
AbbVie USD 37.48B 3.81B 2026-09
Abbott USD 23.5B 1.02B 2026-09
Amgen USD 34.36B 598M 2026-09
AstraZeneca USD 31.45B 3.48B 2026-09
Baxter International USD 6.83B 163M 2026-09
Bayer EUR 39.6B 5.96B 2026-09
Becton, Dickinson and Co. USD 8.32B 178M 2026-09
Biogen USD 7.58B 278.7M 2026-09
Boston Scientific USD 8.16B 192M 2026-09
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
CONMED USD 682.04M 6.37M 2026-09
Cooper Companies USD 2.28B 18.3M 2026-06
Dexcom USD 3.92B 170.6M 2026-09
Edwards Lifesciences USD 7.25B 428.6M 2026-09
Eli Lilly USD 65.26B 591M 2026-09
Gilead Sciences USD 16.55B 4.02B 2026-09
GlaxoSmithKline GBP 17.9B 336M 2026-09
Globus Medical USD 2.18B 33.55M 2026-09
Insulet USD 2.04B 192.4M 2026-09
Integra LifeSciences USD 1.19B 1.54M 2026-09
Intuitive Surgical USD 10.65B 1.68B 2026-09
J&J USD 56.35B 3.42B 2026-09
Medtronic USD 24.39B 397M 2026-06
Merck USD 38.94B 2.26B 2026-09
Merit Medical Systems USD 1.2B 86.58M 2026-09
Novartis USD 28.75B 1.4B 2026-09
Pfizer USD 45.01B 3.65B 2026-09
Regeneron Pharmaceuticals USD 20.8B 2.35B 2026-09
Roche Holding CHF 35.44B 3.29B 2026-06
Sanofi EUR 33.21B 1.68B 2026-09
Stryker USD 14.18B 235M 2026-09
Tandem Diabetes Care USD 820.72M 16.08M 2026-09
Teva Pharmaceutical Industries USD 14.6B 842M 2026-09
Vertex Pharmaceuticals USD 11.69B 857.4M 2026-09
Zimmer Biomet Holdings USD 5.13B 32.3M 2026-09
Zoetis USD 6.29B 63M 2026-09